The Cannigma

FEBRUARY 21, 2021

Really large European ag-techs, really large North American CPG (consumer packaged goods) companies, Big Tobacco — they’re ready to make moves. They are making those moves,” said Jake Kuczeruk, vice president of business development at The Arcview Group, a cannabis investment, consulting, and research group. billion by 2024.

Research and Development 118

Research and Development Pharmaceutical Recreational Cannabis 118

MMJ Recs

OCTOBER 2, 2023

These cover various aspects, including cultivation, manufacturing, testing, packaging, and labeling of medical cannabis products. Dispensaries and other cannabis businesses must comply with these regulations to maintain their licenses and uphold the integrity of the medical marijuana industry.

Dispensary 52

Dispensary Patients Environment Conditions 52

Marijuana Packaging

NOVEMBER 2, 2018

It was an oddly close call for the industry as a whole, since a win for the horse ranch threatened to open a Pandora’s box of similar lawsuits aimed at other cannabis industry businesses. Epidiolex is an orally administered medication designed to treat certain types of epilepsy in patients age 2-years and older.

History 40

History Programs Epilepsy Patients 40

Cannabis Law Report

FEBRUARY 17, 2020

It all hinges solely on a vertical integration business model , which includes licensed cannabis businesses in Florida. That is, these licensed companies eventually dispense a patient’s doctor-issued recommendation by first planting and cultivating medical cannabis before processing and packaging it. Crohn’s Disease.

Dispensary 76

Dispensary Patients Agriculture Conditions 76

CannaMD

SEPTEMBER 15, 2020

Patients suffering from cancer, epilepsy, chronic seizures, or muscle spasms could use low-THC cannabis products recommended by a licensed doctor. However, billing companies and other entities that work directly with your medical marijuana clinic may have access to your information as it pertains to their role as a business associate.

Law 126

Law Marijuana Patients Treatment 126

The Joint Blog

SEPTEMBER 19, 2019

Yet people behind spiked products have operated with impunity, in part because the business has boomed so fast that regulators haven’t caught up while drug enforcement agents have higher priorities. The packaging doesn’t identify the companies and their brands have little online presence.

Vaping 44

Vaping Oil CBD Marijuana 44

Cannabis Law Report

APRIL 10, 2019

In relation to childhood epilepsy, the British Paediatric Neurology Association has issued interim clinical guidance. There is evidence that CBD may be beneficial in the treatment of intractable epilepsy, and over 80 children have already been supplied with CBD products in the UK on the basis of a specialist doctor’s prescription.

Clinical Trials 51

Clinical Trials Epilepsy Medicine Research and Development 51

The Cannigma

APRIL 7, 2022

Their beautiful packaging and marketing will put a link in the show notes. MB: Right, but one thing that is interesting is that my contention is that we put terps aside and started chasing THC content, because, I mean, you watch even at the time I’ve been in the business, the average THC content is gone from about 15 to close to 30 now.

Terpenes 52

Terpenes Wellness and Beauty Cannabis Extraction 52

Cannabis Law Report

NOVEMBER 10, 2021

–(BUSINESS WIRE)– #pharma — Virpax ® Pharmaceuticals, Inc. Once completed, it is our intention to immediately submit our IND package to the FDA so that we may begin human trials,” commented Virpax’s Chairman & CEO Anthony P. For more information, please visit www.virpaxpharma.com. Forward-Looking Statement.

Research and Development 52

Research and Development Chronic Pain Pharmaceutical Clinical Trials 52

Cannabis Law Report

NOVEMBER 15, 2021

–(BUSINESS WIRE)– #earnings — Virpax ® Pharmaceuticals, Inc. We are looking forward to the completion of the required IND enabling studies and submitting our IND package to the FDA in anticipation of first-in-human trials,” continued Mr. Mack. VRP324 represents our first CNS disorder product indication.

Pharmaceutical 52

Pharmaceutical Research and Development Clinical Trials Chronic Pain 52

The Cannigma

DECEMBER 22, 2021

Today’s guest is Itai Rogel, the Vice President of Business Development at Israeli cannabis company, Bazelet. I recorded the VP of business development from an Israeli cannabis company called Bazelet. He is the VP of Business Development and Marketing. We have autism and epilepsy. I’m Elana Goldberg.

Research and Development 79

Research and Development Oil Cannabis Clinical Trials 79

Cannabis Law Report

OCTOBER 17, 2019

But the global legal landscape is confusing and constantly evolving, making it essential for people and businesses around the world to secure strong legal representation. There are also ancillary businesses that have shown immense growth,” says Gil Selinger , a lawyer at Fairfield and Woods, P.C. (Denver, Colorado, USA).

Law 40

Law Seed-To-Sale Hemp Recreational 40

SpeedWeed

MAY 7, 2021

That specific amendment was grouped with several other committee amendments as one package, which passed as a single vote Thursday on the House floor, 72-26. If enacted, S.B. In addition, minors could not use—or be recommended—more than 3% THC. And employers could still drug test and prohibit employees from using cannabis.

Legislation 52

Legislation Seed-To-Sale Patients Chronic Pain 52

Cannabis Law Report

DECEMBER 30, 2019

House Committee on Small Business Highlights Need for Federal Reforms. On June 19, 2019, the House Committee on Small Business held a hearing entitled “ Unlocked Potential? 1200, would allow state-licensed marijuana-related businesses to engage freely in relationships with banks and other financial institutions.

Legislation 59

Legislation Patients Access Banking 59

SpeedWeed

MAY 19, 2021

That specific amendment was grouped with several other committee amendments as one package, which passed as a single vote May 6 on the House floor, 72-26. When enacted, S.B. In addition, minors cannot use—or be recommended—more than 3% THC. And employers can still drug test and prohibit employees from using cannabis.

Legislation 52

Legislation Seed-To-Sale Patients Conditions 52

SpeedWeed

MAY 18, 2021

That specific amendment was grouped with several other committee amendments as one package, which passed as a single vote May 6 on the House floor, 72-26. When enacted, S.B. In addition, minors cannot use—or be recommended—more than 3% THC. And employers can still drug test and prohibit employees from using cannabis.

THC 52

THC Legislation Seed-To-Sale Patients 52

SpeedWeed

MAY 17, 2021

That specific amendment was grouped with several other committee amendments as one package, which passed as a single vote May 6 on the House floor, 72-26. When enacted, S.B. In addition, minors cannot use—or be recommended—more than 3% THC. And employers can still drug test and prohibit employees from using cannabis.

Legislation 52

Legislation Seed-To-Sale Patients Conditions 52

SpeedWeed

MAY 17, 2021

That specific amendment was grouped with several other committee amendments as one package, which passed as a single vote May 6 on the House floor, 72-26. When enacted, S.B. In addition, minors cannot use—or be recommended—more than 3% THC. And employers can still drug test and prohibit employees from using cannabis.

Legislation 52

Legislation Seed-To-Sale Patients Conditions 52

SpeedWeed

MAY 10, 2021

That specific amendment was grouped with several other committee amendments as one package, which passed as a single vote Thursday on the House floor, 72-26. If enacted, S.B. In addition, minors could not use—or be recommended—more than 3% THC. And employers could still drug test and prohibit employees from using cannabis.

Recreational 52

Recreational Marijuana Legislation Seed-To-Sale 52

SpeedWeed

MAY 8, 2021

That specific amendment was grouped with several other committee amendments as one package, which passed as a single vote Thursday on the House floor, 72-26. If enacted, S.B. In addition, minors could not use—or be recommended—more than 3% THC. And employers could still drug test and prohibit employees from using cannabis.

Legislation 52

Legislation Seed-To-Sale Patients Chronic Pain 52

SpeedWeed

MAY 7, 2021

That specific amendment was grouped with several other committee amendments as one package, which passed as a single vote Thursday on the House floor, 72-26. If enacted, S.B. In addition, minors could not use—or be recommended—more than 3% THC. And employers could still drug test and prohibit employees from using cannabis.

Legislation 52

Legislation Seed-To-Sale Patients Chronic Pain 52

SpeedWeed

MAY 18, 2021

That specific amendment was grouped with several other committee amendments as one package, which passed as a single vote May 6 on the House floor, 72-26. When enacted, S.B. In addition, minors cannot use—or be recommended—more than 3% THC. And employers can still drug test and prohibit employees from using cannabis.

Legislation 52

Legislation Seed-To-Sale Patients Conditions 52

SpeedWeed

MAY 10, 2021

That specific amendment was grouped with several other committee amendments as one package, which passed as a single vote Thursday on the House floor, 72-26. If enacted, S.B. In addition, minors could not use—or be recommended—more than 3% THC. And employers could still drug test and prohibit employees from using cannabis.

Legislation 52

Legislation Seed-To-Sale Patients Chronic Pain 52